Singapore-based Qritive, a startup that uses artificial intelligence to improve cancer diagnosis and patient care, has raised $7.5 million in a Series A funding round led by MassMutual Ventures, with participation from Seeds Capital and Exfinity Venture Partners.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in